Vestipitant
Sponsors
GlaxoSmithKline, Accenture
Conditions
Depressive Disorder and Anxiety DisordersPostoperative Nausea and VomitingTinnitus
Phase 2
PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
CompletedNCT00343707
Start: 2004-11-30End: 2005-11-30Updated: 2016-09-15
Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
CompletedNCT00394056
Start: 2006-12-31End: 2009-08-31Updated: 2016-10-28
A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)
CompletedNCT01507194
Start: 2012-02-29End: 2012-08-31Updated: 2012-10-02